Erectile Dysfunction Treatment Market Growth Accelerated by Rise in Public Awareness


 Erectile dysfunction refers to the inability to develop and maintain an erection firm enough for sexual activity. Erectile dysfunction drugs help enhance smooth muscle relaxation in the corpus cavernosum of the penis, allowing increased blood flow, resulting in an erection. Rising public awareness about erectile dysfunction and increasing acceptance of erectile dysfunction treatment have accelerated the growth of the erectile dysfunction treatment market over the years. The global Erectile Dysfunction Treatment Market is estimated to be valued at US$ 4.54 Bn in 2023 and is expected to exhibit a CAGR of 7.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
The increasing adoption of minimally invasive and non-invasive treatment options has been one of the major trends witnessed in the erectile dysfunction treatment market. Various minimally invasive procedures like penile implants, penile injection therapy using drugs like alprostadil, and vacuum therapy have gained immense popularity as they are highly effective with less downtime. Similarly, non-invasive options like sound wave therapy, localized heat therapy, and low-intensity shockwave therapy offer promise with no surgical risks. Their cost-effectiveness and negligible side effects compared to oral drugs and surgeries have made them the treatment of choice, especially among younger men. This rising popularity of new treatment avenues is expected to propel the erectile dysfunction treatment market substantially going forward.

Segment Analysis
The global erectile dysfunction treatment market is dominated by oral medications sub-segment. Oral medications such as Sildenafil, Tadalafil, and Vardenafil are very effective, have few side effects and are relatively inexpensive compared to other treatments. These drugs have revolutionized the treatment of erectile dysfunction as they are easy to use and have a good success rate.

Key Takeaways
The global erectile dysfunction treatment market is expected to witness high growth. The market size is projected to reach US$ 4.54 Billion by 2024, growing at a CAGR of 7.6% during the forecast period of 2023 to 2030.

Regional analysis: North America currently dominates the erectile dysfunction treatment market and is expected to continue its dominance over the forecast period. This is attributed to the rising awareness levels regarding erectile dysfunction and its treatment options in the region. Asia Pacific is expected to be the fastest growing market due to increasing obesity levels, sedentary lifestyles and rising medical tourism in the region.

Key players operating in the erectile dysfunction treatment market are Mangoceuticals, Inc, Futura Medical, CURE Pharmaceutical Holding Corp, Glenmark Pharmaceuticals Ltd, Mylan Pharmaceuticals Inc., Boston Scientific, Cipla Ltd, Pfizer Inc., Coloplast CORP, Eli Lily & Co, Gust Inc, Altera, Promedon, Dr. Reddys Laboratories Ltd, Bayer Pharma AG, and Reflexonic LLC.

Comments

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure